Schwaneke Jeffrey A. 4
4 · agilon health, inc. · Filed Jul 3, 2024
Insider Transaction Report
Form 4
Schwaneke Jeffrey A.
Chief Financial Officer
Transactions
- Award
Common Stock
2024-07-01+377,074→ 441,124 total - Award
Common Stock
2024-07-01+131,976→ 573,100 total - Award
Common Stock
2024-07-01+150,830→ 723,930 total - Award
Options (Rights to Buy)
2024-07-01+239,072→ 239,072 totalExercise: $6.07Exp: 2034-07-01→ Common Stock (239,072 underlying)
Footnotes (5)
- [F1]Restricted stock units that vest in three equal installments on each anniversary of July 1, 2024.
- [F2]Includes restricted stock units.
- [F3]Restricted stock units that vest in four equal installments on each anniversary of July 1, 2024.
- [F4]Performance Stock Units may become vested subject to attainment (based on 40 trading day average closing price, exceeding twice the closing price of the Company's stock price on date of grant) and within three years from grant date.
- [F5]Options that vest in four equal installments on each anniversary of July 1, 2024.